FILTERED RESULTS
FILTERS
Ads Top
•
·
·
FILTERED RESULTS
RBC Capital Markets Names Top US E&P Stocks
Oil rises on US-Iran friction over Hormuz
According to the BOJ quarterly survey in March, 83.7% of households in Japan expect higher prices in...
Copper Wavers Near Two-Month High as US-Iran Tensions Escalate
TD Cowen reduces its target price on TotalEnergies to $102 versus $106 earlier....
South Africa Steel Needs Demand Not Belligerence, Regulator Says
Iran War Deepens China’s Dependence on the US for Niche Gas
The looming battle over the Fed’s balance sheet
Thailand’s deputy prime minister announces plans for a law allowing 500 billion baht in government...
Market Uncertainty Grows Amid Iran's Strait of Hormuz Tensions
AST SpaceMobile's BlueBird 7 Satellite Deployed Incorrectly, Rendered Unusable
Amazon Acquires Globalstar to Enhance Satellite Connectivity
Flutter Entertainment Shares Decline Nearly 50% Over Past Year
CRH Launches $300 Million Share Buyback Program
Microsoft Expands AI and Cloud Initiatives in Automotive Sector
Thailand Plans New Law for 500 Billion Baht Government Borrowing
Thailand Considers Increasing Public Debt Ceiling
The yield on the 5-year Japanese government bond eases by 2 basis points to 1.815%....
US Seizes Iranian Ship, Peace Talks in Doubt
BAT sees its price target reduced by AlphaValue to 4,233p, down from 4,272p....
Analysis-European defence stocks cool as investors reassess war winners
Jefferies increases its target price on Prologis to $163 versus $155 earlier....
Blue Origin's New Glenn Rocket Successfully Lands, Satellite Deployment Fails
Agoda Introduces 'What a Save!' Campaign in India
Interactive Brokers Set to Announce Earnings Results Tomorrow
Capital One Scheduled to Release Earnings Report Tomorrow
Northrop Grumman Set to Announce Earnings Tomorrow
Hong Kong Banks Experience Easing Earnings Strain Amid Improved Cross-Border Flows
India’s 10-year benchmark government bond yield rises to 6.9094% from the previous close of...
Global 2025 Power Demand Rose as EV, Data Centers Grew, IEA Says
Oil rises 5% on renewed US-Iran tension
Manycore shares extend rally after doubling in Hong Kong IPO debut
Huawei signs deal with Vietnamese bank SHB to expand Vietnam footprint
Japan households’ inflation expectations roughly steady, BOJ survey shows
Morning Bid: Markets light on volume and high on hopes
The ECB is now seen delivering 25 bps rate hikes in June and September 2026, according to Barclays,...
European Natural Gas Rises as Iran Closes Strait of Hormuz Again
Investment Strategy for AI Stocks with $10,000
India's 10-Year Government Bond Yield Increases to 6.9094%
Indian Rupee Opens Stronger Against US Dollar
The China Show 4/20/2026 (Video)
Humanoid Robot Beats Human Record in Beijing
Russia’s Tuapse port is set ablaze in a “massive” Ukrainian drone attack, with one person killed,...
White House: Trump will participate today in a closed political meeting away from the media...
Samsung Signs EV Battery Deal with Mercedes Amid Plant Transition in Hungary
ECB Expected to Raise Rates in June and September 2026
Trump is set to participate in a private political meeting today with no media access, according to...
AirAsia Tests Market With Deutsche-Led $230 Million Private Debt
Trump's Energy Secretary Has 'Outdated' Optimism On Gas Prices, Says Economist, Hormuz Risks Mean 'Expensive Gas Isn't Going Anywhere'
GSK Gains Regulatory Approvals for Respiratory Treatment and Advances Cancer Pipeline
GSK has received regulatory approvals in China and the European Union for depemokimab, marketed as Exdensur. This treatment is recognized as a first-in-class ultra long-acting biologic aimed at addressing specific respiratory conditions. The new approvals significantly enhance the global commercial presence of depemokimab in major markets.
In addition to the respiratory treatment, GSK announced encouraging phase 1 trial results for Mo Rez, an antibody drug conjugate targeting B7 H4, which is intended for use in challenging gynecologic cancers. This development underscores the company's commitment to advancing its oncology pipeline.
GSK also reported progress on AlpE, a partnered program, indicating ongoing efforts to expand its portfolio in both respiratory and oncology sectors. These advancements reflect GSK's strategic focus on innovative therapies to meet unmet medical needs.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News